Muhsen Al-Dhalimy

8.2k total citations · 4 hit papers
28 papers, 6.2k citations indexed

About

Muhsen Al-Dhalimy is a scholar working on Clinical Biochemistry, Molecular Biology and Hepatology. According to data from OpenAlex, Muhsen Al-Dhalimy has authored 28 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Biochemistry, 11 papers in Molecular Biology and 9 papers in Hepatology. Recurrent topics in Muhsen Al-Dhalimy's work include Metabolism and Genetic Disorders (12 papers), Liver physiology and pathology (9 papers) and Pancreatic function and diabetes (6 papers). Muhsen Al-Dhalimy is often cited by papers focused on Metabolism and Genetic Disorders (12 papers), Liver physiology and pathology (9 papers) and Pancreatic function and diabetes (6 papers). Muhsen Al-Dhalimy collaborates with scholars based in United States, Canada and Netherlands. Muhsen Al-Dhalimy's co-authors include Markus Grompe, Milton J. Finegold, Eric Lagasse, Xin Wang, Ken Overturf, Heather Connors, Michael J. Reitsma, Monika Dohse, Irving L. Weissman and Linda J. Osborne and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Muhsen Al-Dhalimy

28 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo

2000 1.8k citations Eric Lagasse, Heather Connors et al. Nature Medicine profile →
Cell fusion is the principal source of bone-marrow-derived hepatocytes

2003 1.2k citations Xin Wang, Holger Willenbring et al. Nature profile →
Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice

2007 598 citations Hisaya Azuma, Nicole K. Paulk et al. Nature Biotechnology profile →
Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes.

1997 446 citations Ken Overturf, Muhsen Al-Dhalimy et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Muhsen Al-Dhalimy United States	23	3.0k	2.7k	2.6k	1.7k	778	28	6.2k
Eric Lagasse United States	35	2.7k 0.9×	4.0k 1.5×	1.7k 0.7×	1.9k 1.1×	578 0.7×	69	7.9k
Susan B. Olson United States	37	1.2k 0.4×	4.1k 1.5×	747 0.3×	950 0.6×	1.3k 1.7×	112	6.5k
Rosemary Jeffery United Kingdom	37	2.1k 0.7×	2.5k 0.9×	843 0.3×	1.3k 0.8×	525 0.7×	59	5.9k
Philippe Leboulch United States	43	1.1k 0.4×	3.8k 1.4×	589 0.2×	1.2k 0.7×	1.8k 2.3×	113	5.9k
Anne Dubart‐Kupperschmitt France	35	431 0.1×	2.2k 0.8×	421 0.2×	418 0.2×	708 0.9×	109	3.8k
Ingrid Laurendeau France	38	466 0.2×	2.1k 0.8×	774 0.3×	216 0.1×	476 0.6×	63	4.2k
K. Michael Weidner Germany	32	1.5k 0.5×	3.5k 1.3×	3.1k 1.2×	163 0.1×	348 0.4×	44	5.8k
I D Goldberg United States	26	545 0.2×	1.5k 0.5×	958 0.4×	205 0.1×	447 0.6×	39	3.0k
Hendrik Ungefroren Germany	41	687 0.2×	2.9k 1.1×	261 0.1×	371 0.2×	262 0.3×	130	5.4k

Countries citing papers authored by Muhsen Al-Dhalimy

Since Specialization

Citations

This map shows the geographic impact of Muhsen Al-Dhalimy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhsen Al-Dhalimy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhsen Al-Dhalimy more than expected).

Fields of papers citing papers by Muhsen Al-Dhalimy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhsen Al-Dhalimy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhsen Al-Dhalimy. The network helps show where Muhsen Al-Dhalimy may publish in the future.

Co-authorship network of co-authors of Muhsen Al-Dhalimy

This figure shows the co-authorship network connecting the top 25 collaborators of Muhsen Al-Dhalimy. A scholar is included among the top collaborators of Muhsen Al-Dhalimy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhsen Al-Dhalimy. Muhsen Al-Dhalimy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moghrabi, Nabil, Monique Johnson, Muhsen Al-Dhalimy, et al.. (2009). Validation of Fanconi anemia complementation Group A assignment using molecular analysis. Genetics in Medicine. 11(3). 183–192. 14 indexed citations

Hejna, James, et al.. (2008). Tip60 Is Required for DNA Interstrand Cross-link Repair in the Fanconi Anemia Pathway. Journal of Biological Chemistry. 283(15). 9844–9851. 24 indexed citations

Azuma, Hisaya, Nicole K. Paulk, Aarati R. Ranade, et al.. (2007). Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice. Nature Biotechnology. 25(8). 903–910. 598 indexed citations breakdown →

Hamman, Kelly, Heather D. Clark, Eugenio Montini, et al.. (2005). Low Therapeutic Threshold for Hepatocyte Replacement in Murine Phenylketonuria. Molecular Therapy. 12(2). 337–344. 48 indexed citations

Vogel, Arndt, Inge E.T. van den Berg, Muhsen Al-Dhalimy, et al.. (2004). Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death. Hepatology. 39(2). 433–443. 43 indexed citations

Wang, Xin, Holger Willenbring, Yassmine Akkari, et al.. (2003). Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature. 422(6934). 897–901. 1202 indexed citations breakdown →

Al-Dhalimy, Muhsen, Ken Overturf, Milton J. Finegold, & Markus Grompe. (2002). Long-Term Therapy with NTBC and Tyrosine-Restricted Diet in a Murine Model of Hereditary Tyrosinemia Type I. Molecular Genetics and Metabolism. 75(1). 38–45. 65 indexed citations

Montini, Eugenio, Patrice K. Held, Meenakshi Noll, et al.. (2002). In Vivo Correction of Murine Tyrosinemia Type I by DNA-Mediated Transposition. Molecular Therapy. 6(6). 759–769. 112 indexed citations

Wang, Xin, Eugenio Montini, Muhsen Al-Dhalimy, et al.. (2002). Kinetics of Liver Repopulation after Bone Marrow Transplantation. American Journal Of Pathology. 161(2). 565–574. 192 indexed citations

10.

Lagasse, Eric, Heather Connors, Muhsen Al-Dhalimy, et al.. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nature Medicine. 6(11). 1229–1234. 1796 indexed citations breakdown →

11.

Overturf, Ken, Muhsen Al-Dhalimy, Milton J. Finegold, & Markus Grompe. (1999). The Repopulation Potential of Hepatocyte Populations Differing in Size and Prior Mitotic Expansion. American Journal Of Pathology. 155(6). 2135–2143. 143 indexed citations

12.

Grompe, Markus, Ken Overturf, Muhsen Al-Dhalimy, & Milton J. Finegold. (1998). Therapeutic trials in the murine model of hereditary tyrosinaemia type I: A progress report. Journal of Inherited Metabolic Disease. 21(5). 518–531. 37 indexed citations

13.

Overturf, Ken, et al.. (1998). Ex Vivo Hepatic Gene Therapy of a Mouse Model of Hereditary Tyrosinemia Type I. Human Gene Therapy. 9(3). 295–304. 49 indexed citations

14.

Overturf, Ken, Muhsen Al-Dhalimy, Milton J. Finegold, & Markus Grompe. (1997). Serial transplantation reveals stem cell like regenerative potential in parenchymal mouse hepatocytes. The FASEB Journal. 11(3). 3 indexed citations

15.

Overturf, Ken, Muhsen Al-Dhalimy, Ching N. Ou, et al.. (1997). Adenovirus-Mediated Gene Therapy in a Mouse Model of Hereditary Tyrosinemia Type I. Human Gene Therapy. 8(5). 513–521. 58 indexed citations

16.

Overturf, Ken, Muhsen Al-Dhalimy, C N Ou, Milton J. Finegold, & Markus Grompe. (1997). Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes.. PubMed. 151(5). 1273–80. 446 indexed citations breakdown →

17.

Grompe, Markus, et al.. (1994). A Single Mutation of the Fumarylacetoacetate Hydrolase Gene in French Canadians with Hereditary Tyrosinemia Type I. New England Journal of Medicine. 331(6). 353–357. 88 indexed citations

18.

Grompe, Markus & Muhsen Al-Dhalimy. (1993). Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I. Human Mutation. 2(2). 85–93. 40 indexed citations

19.

Grompe, Markus & Muhsen Al-Dhalimy. (1992). Nucleotide sequence of a cDNA encoding murine fumarylacetoacetate hydrolase. Biochemical Medicine and Metabolic Biology. 48(1). 26–31. 13 indexed citations

20.

Litt, M., Muhsen Al-Dhalimy, Qun Zhou, David K. Grandy, & Olivier Civelli. (1991). A Taql RFLP at the DRD1 locus. Nucleic Acids Research. 19(11). 3161–3161. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact